Clinical Trial Update: FMT and Fiber in Patients With Metabolic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating fecal microbiota transplantation (FMT) and dietary fiber in patients with obesity and metabolic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Obesity

Snippet

Sponsor: University of Alberta | Conditions: Obesity, Metabolic Syndrome | Phase 2 | Status: COMPLETED